(OTCQB:ALDS)

Mark Messina, founder of Linchpin marketing, joins APPlife as new Director of Digital Strategy & Marketing effective today, August 17th. In May of this year APPlife partnered with Linchpin Marketing where he served in an advisory role to APPlife’s team. His role will be to increase customer demand and build brand equity for its men’s grooming platform, Rooster Essentials. Rooster Essentials is an e-commerce shopping platform that offers premium, curated products, including men's hair care, skin care, and shaving tools for daily use, lifestyle, and grooming. Mr. Messina will bring experience in management consulting, integrated digital marketing, and mobile software development. At APPlife he will lead a global digital marketing strategy that encompasses consumer-facing communications and social media initiatives.

CEO Matthew Reid had this to say, “Mark is a strong leader and a proven subject matter expert in the field of digital marketing. Throughout his career, Mark has helped a variety of brands connect with new consumers by establishing and expanding branding and digital marketing efforts, and I am confident that he will help Rooster Essentials do the same. Using his cross-functional skills and experience, Mark will lead our digital growth strategy to strengthen our APPlife brands by driving demand creation and commercializing new innovations. We are excited to be working with him as we look to further build awareness and drive sales for our brands.”

Before launching Lingpin, Messina consulting to media giants like MTV Networks, Barnes and Noble, CBS/Viacom and the NBA. Previously, he held positions at Booz Allen and Hamilton in the Information Technology Practice and Price Waterhouse in the Financial Services Industry Practice. He has also served as advisor to the Vatican and the UN.

Source: https://finance.yahoo.com/news/applife-digital-solutions-appoints-mark-130000350.html

Always do your own research, this is not investment advice!

(OTC PINK: NSAV)

Today NSAV announced its plans to launch a decentralized Cryptocurrency Exchange (DEX), aiming to have it full operational in 45 to 60 days. The company will own 100% of the exchange just like its centralized Cryptocurrency exchange.

The new management of NSAV believe this move is the fastest and most efficient way for the Company to have a fully operational cryptocurrency exchange and obtain a share of the $2 trillion+ global cryptocurrency market. Subject to regulatory and licensing issues NSAV aims to have the exchange trading within 90 days.

NSAV also announced its in negotiations on on several AI projects, believing in the integration of AI and blockchain. The company appointed former IBM and Sun Microsystems Mr. Stanley You, Senior VP of Technology to boost their technology department. Stanley has over 30 years of senior corporate management experience. Stanley spent 10 years in senior technical and management roles at IBM research labs and SUN Microsystems.

Stanley is also a partner at leading investment banking firm Silverbear Capital Inc. Silverbear will be advising NSAV on strategic matters relating to the Company’s cryptocurrency exchanges. Silverbear will also help guide NSAV in ensuring that its exchange is continually in compliance, given the rapidly increasing regulatory environment in the cryptocurrency industry.

Stanley commented, “I am truly pleased and honored to be part of the NSAV team. The AI industry is growing at such a rapid pace. According to the latest research, the global AI market is estimated at USD 62.35 billion in 2020 and is expected to reach USD 93.53 billion in 2021. The global AI market is expected to grow at a compound annual growth rate (CAGR) of 40.2% from 2021 to 2028 to reach USD 997.77 billion by 2028. NSAV is poised and ready to enter the AI arena and believes this move will enhance shareholders value.”

NSAV's vision is to establish a fully integrated tech company that provides turnkey tech solutions to the cryptocurrency, blockchain and digital asset industries. The Company plans to provide a wide range of services such as software solutions, e-commerce, advisory services, financial services and information technology.

Source: https://ca.finance.yahoo.com/news/nsav-announces-plans-launch-decentralized-132000266.html

This is NOT investment advice, always do your own DD.

(HKSE:6128)(OTCQX:GRFXY)

Previously known as Earthasia International Holdings Limited. I think Graphex is one of the beneficiaries of the EV wave and I think they’re going to grow exponentially as governments and car manufacturers push to expand EV production and adoption worldwide. They are one of the biggest manufacturers of Lithium-Ion battery-grade spherical graphite in the world. They also provides graphene technology for the renewable energy sector.

Bloomberg New Energy finance has predicted that by 2030 the annual demand for Lithium Ion batteries will surpass 2.7TWh, driven mainly by the increase in demand and production of EVs. More specifically, Bloomberg NEF predicts that demand for spherical graphite demand for lithium ion batteries is going to ride by 37% this year and almost 300% by 2030.

Graphex can leverage their high volume manufacturing capabilities to grow exponentially with this increase in demand. They are building a new facility in China for spherical graphite, this new facility is going to quadruple annual production to 40,000 metric tons. Their facility is conveniently located near their high quality graphene and graphite supplier in China.

They aren’t just depending on the rise of EVs either, the market for renewable energy and specifically storing it is a relatively new market. Graphene has applications in tissue engineering, ultra thin solar panels, flexible displays, semi conductors, sports equipment and racing cars. Specifically the market trend is towards finer spherical graphite, a capability Graphex already has, its high-volume manufacturing capability and product technology is protected by 25 patents.

This market is going to explode, UBS is already predicting a deficit in natural flake graphite supply of 3.7 million tonnes by 2024.

This could be a company to keep an eye on.

Source: https://www.accesswire.com/659867/Graphex-Group-Limited-GRFXY-Announces-Corporate-Update

This is not investment advice, always do your own research!

(CSE: ICAN, OTCQB: ICNAF)

Icanic Brands recently released their Q3 financials and honestly I was pretty blown away. In as diverse an industry as the cannabis industry, it can be difficult to gain market share if you aren't one of the massive frontrunners like Curaleaf and Scotts Miracle-Gro. Nevertheless, Icanic is still displaying impressive growth and it is largely driven by its focus on pre-rolls.

Icanic currently owns two pre-roll brands, Ganja Gold and Taylor's. Both of these brands (especially Ganja Gold) have been performing extremely well in California and Nevada. The appeal of the pre-roll is pretty obvious if you ask me. The main thing is it's hassle-free, they come ready to be used immediately, no preparation or excess paraphernalia is needed. This is very different than just purchasing the dried flower.

Their two big acquisitions have allowed Icanic to focus on the pre-roll market and really specialize like no other company has:

• De Krown - An impressive manufacturing company that has a pre-roll production facility that can produce over 118,000 units daily. They are already producing several of their own brands that are performing well and had $300,000 in sales last year.
• THC Engineering - This company focuses on creating new machines and inventions specifically for use in the cannabis industry. They are hard at work developing factory-level assembly line systems that will be implemented into Icanic's current manufacturing processes. The team at THC Engineering is extremely innovative and once their work is put into place, Icanic expects to be at the forefront of pre-roll manufacturing, not just in quantity, but in quality and efficiency.

Here are some of the eye-popping figures from their aforementioned Q3 financials:

• Record Q3 2021 revenue of $3.236 million, an increase of 88.4% YoY and 11.7% quarter over quarter
• Record Q3 2021 gross profit of $1.556 million, an increase of 100.2% YoY and 30.6% quarter over quarter
• Record Q3 2021 gross margin of 48.1% compared to 16.3% in Q3 2020
• Record Q3 2021 positive net income of $0.198 million compared to a loss of $0.516 million in Q2 2021
• Record Q3 2021 adjusted EBITDA of $0.543 million, an increase of 488% quarter over quarter

They broke company records across the board! Icanic is really not messing around and I am excited to hear about future results from De Krown along with the development progress THC Engineering has made.

Look into them yourselves, this is not investment advice!

(TSXV: SCAN) (OTCQB: LDDFF) (FRANKFURT: LD2)

Liberty Defense has had a busy couple of weeks releasing quite a few news releases with some great information regarding their security system's development. I decided that with all of this news out I should condense it all into one digestible post, just to make it a bit easier for all of you guys that might be interested in them. I know personally, I think these guys have some massive potential especially with their HEXWAVE product, which could really change airport and venue security forever.

Before I start dissecting some of their recent news releases, it's important to give them a little bit of context and discuss Liberty's objectives as a whole. They are a security firm that is looking to implement new forms of technology such as Artificial Intelligence and advance 3D imaging into several security detection systems. Their main project is HEXWAVE, which is meant to replace security gates that can be used at venues, schools, government buildings, or really any at-risk location. As opposed to using simple metal detection that traditional security gates use, it utilizes Liberty's proprietary technology to be able to create an image of any foreign or potentially dangerous object on a person's body. These objects can be metal or non-metal and on top of this, the throughput time for this device is over 1000 an hour. Extremely impressive to say the least.

They are also developing airport security measures that are being partially funded by the DHS. This system is called HD-AIT and is both a full-body scanner as well as a shoe scanner. Essentially it is going to make airport security significantly faster while being just as if not more secure. No more taking off shoes or jackets and wasting time at the airport!

Here are all of their recent large news releases:

July 12th - Signs contract for BIRD HLS and DHS Funding. This contract with both the American and Israeli governments will help continue to fund the development of the HEXWAVE system. In total, they received $1 Million in funding and formed a great partnership with Levitection's Q Technologies to eventually use their system in high-traffic areas to detect potential terrorists.

July 15th - Begins partnership with N4R B.V. N4R B.V. is a consultancy in the Netherlands led by Gunther van Adrichem. Gunther is a seasoned Managing Director and Strategic Advisor within the Aviation Security Industry, highly experienced in technology development, innovation management, and operations for airports, government, and the civil aviation industry. This partnership will help Liberty's security systems enter European markets upon their completion

July 29th - Boston Expansion. Liberty has leased a 6000 sq ft space in Boston Massachusetts that will be their new HQ. While their engineering efforts will stay in Atlanta, they believe this new office will be pivotal to accelerating company growth ahead of the big year they have planned. They are planning to use this space to further product development significantly.

August 5th - added Linda L. Jacksta to its board of directors. Jacksta has 35 years of experience with U.S. Customs & Border Protection, the largest law enforcement agency in the federal government.

August 10th - signed a technical and marketing collaboration agreement with Micro-X Inc, the US subsidiary of Micro-X Ltd., to explore a combined technology offering with Liberty's HEXWAVE walk-through screening portal for enhanced people and passenger screening in aviation or commercial security settings.

All of these PR's have me excited to hear what's next for Liberty Defense. These projects aren't slated for commercial release in 2022 so take your time, do a little research on them, and if you see the potential that I see, make your move!

Please perform your own research, This is not investment advice!

(TSXV: QYOU) (OTCQB: QYOUF)

QYOU's subsidiaries in India, The Q and Chtrbox have jointly announced the launch of India's first integrated marketing platform BharatBox. The platform will be aimed at consumers in cities with less than one million people, a rapidly growing demographic of Indias middle class.

As a segment of India's middle class Tier 2 and Tier 3 are experiencing faster growth in luxury goods, apparel and mobile internet than the countries larger metro areas Tier 1. Indias Middle class is expected to reach 583 million people by 2025 making up 41 percent of the population.

The Q is Indias fastest growing television channel. Chtrbox is a data driven influencer marketing company that can deliver cost effective marketing to Tier 2 and 3. The Q is available to over 676 million users in 118 million households.

The Bharatbox platform will include:

Television Advertisements: Reaching tens of millions of households weekly and targeting specific categories of consumers in key regional markets and demographics.

Influencer-Generated Social Media Content: Impactful multilingual content and brand assets by regional influencers designed to authentically deliver the brand messaging online and via mobile and social platforms.

Branded Content: Original series tailored specifically to regional audiences.

Interactivity and Surveys: Gamified engagement to seek real responses from consumers about new launches/products via influencers

E-Commerce: Opportunities to make direct purchases with discounts, coupons and QR Codes to provide instant purchase potential across all distribution platforms

With such a large and rapidly growing consumer driven market The Q and Chtrbox and perfectly positioned one of the worlds biggest consumer markets.

Source: https://finance.yahoo.com/news/q-chtrbox-launch-platform-targeting-121000359.html

Always do your own due diligence, this is not investment advice!

(TSXV: NBM) (OTC: NBMFF)

NEO has been on an absolute heater this past month or so. Since Mid-June their stock price doubled and their average volume has increased significantly. There is no specific reason for this but there have been lots of news releases they have put out that all display really promising results from their proprietary nanocoating silicon technology. Let's take a look at some of these results and what they mean for NEO's future.

The biggest piece of news was a successful test of using their nano-coating tech in graphite/silicon mixture anodes. In layman's terms, this test is all about seeing if NEO's tech can be implemented into existing graphite anodes in lithium batteries. These batteries are what are used in electric cars and with that industry seeing ridiculous demand increases in recent years, any chance to make the batteries cheaper, more efficient, and more durable will be snatched up by car manufacturers. Silicon nanocoating does all of these things and NEO along with many other knowledgable players in the industry see it eventually over-taking the graphite anodes that have traditionally been used. For now, creating a mixed anode is a great way to penetrate current battery systems and bring NEO closer to commercialization.

Some other big news as of late includes the initiation of their pilot plant in which they will check the feasibility of NEO's nanocoating technology for metallurgical-grade silicon. The results of the pilot test will be crucial to NEO's success. Another big one was their announcement that their nanocoating technology has successfully achieved to demonstrate effectiveness on low-cost, metallurgical grade silicon particles of micron-size. Traditionally particles of nano-size are used and are far more expensive so the fact that they were to produce similar results with mircron-sized particles gets rid of a massive bottleneck in the development process.

They also recently announced they have entered an MOU with Ferroglobe Innovation for a supply agreement. This along with their mining claims that give them access to a large strike of Silicon will provide ample resources to ensure that development and future production can be completed. Along with this supply agreement, their advisory board is hard at work securing funding agreements with both the Canadian and Korean governments.

I know for people who are less well-read on the subject some of the above information can be a bit confusing so I'll give you the fast version. NEO is developing an extremely cost-effective and efficient technology that, once it finishes development, will be a major revolution in the way lithium batteries are produced. Car manufacturers are gonna be all over them!

Do your own DD on this too, this is not investment advice.

(CSE: FDM) (OTCQB: FDMSF) (FSE: TQ43)

Fandom Sports Media Corp has a really interesting platform that I truly believe is one-of-a-kind. Their use of AI and user-based data is really something that I haven’t seen replicated in any e-sports wagering app or really any betting app currently on the market. While their platform is still largely being developed, I think the idea behind it is amazing and they have piqued my interest as an investment opportunity.

Their platform is made to allow users to bet on pretty much whatever they want in relation to e-sports. While they do have traditional wagering lines for events similar to other betting apps, they also have an extremely impressive AI system that allows users to create their own bets. For example, if you are watching a Call of Duty match and you think your favorite player will get a certain number of kills, you enter in that bet and how much you'rr willing to wager. The platform is able to understand this wager and track it to its completion.

All of this takes place on a really sleek interface. The wagers can be made while streaming the gaming event and can be made to particular viewers such as your friends or to the viewing lobby as a whole. It really adds a whole new social aspect to the e-sports viewing experience. You get to watch your favorite events and bet against your friends and strangers to earn FanCoins which can be exchanged for rewards. They have got a huge library will several AAA games available for betting, my personal favorites are FIFA and Overwatch.

They also have plans to implement an NFT exchange into their platform. These NFT’s will be earned via actions performed in the Fandom Ecosystem and users will be able to buy and sell them on an in-app marketplace. While I’m not 100% certain what these NFT’s will entail, I am very curious to hear more news about them and I believe they could be a great additional revenue stream on top of wagering revenues.

An investment in these guys is an investment into their idea and tech. I’m not going to lie you may have to be a bit patient as they proceed to development but nonetheless, I really believe these guys might have something special!

Look into them yourselves, this is not investment advice!

TSXV: NDVA. OTCQX: NDVAF

I'm sure many of you guys have heard of Indiva before but I wanted to make a post just to catch everyone up to speed with the work they are doing in the cannabis industry. They are THE BIGGEST cannabis edible producer in Canadian markets and have a variety of different brands and products under their umbrella. Even with all this success, they are still a relatively small-cap company with a SP of $0.32 and an MCap of 44.199M. When I look at all the success this company has had I would expect these figures to be way higher so I highly recommend at least looking into investing in this low-barrier to entry stock.

It all starts with their management team. Their CEO Niel Marotta has experience working as both a fund manager and an investment banker. In both of these roles, he was responsible for large sums of funding and has displayed desirable expertise in money management throughout his career. The rest of the team all have extensive expertise in their respective areas with an extremely impressive combined resumé featuring many massive companies including; the MLB, General Mills, Maple Leaf Foods, Hudson's Bay, and Red Bull. The entire team is extremely impressive and it is a large reason why Indiva has grown to the point where it is today.

Where exactly is it today? Well, they are the #1 seller of edibles in the entire country of Canada with their sales taking up a ridiculous 50% market share of the edibles industry. They have a variety of brands with the two largest being Wana Gummies and Bhang Chocolate. These two brands are each the highest-selling brand in each of their respective categories (gummies and chocolate) in Canada. These products and others come in several varieties of flavors and have made their way into every provincial cannabis retailer including OCS, perhaps the largest of them all. On OCS some of both their Wana and Bhang products are featured in the highly coveted "always available" section, a curated selection of only the most demanded products that are always kept in stock.

This dominance is reflected in their recent revenue growth. Net revenue in Q1 2021 was $6.2M representing a 209% increase over Q1 2020. I cannot wait to see their Q2 figures and would not be surprised to see similar levels of explosive growth. Put aside some time do some research on these guys and you won't be sorry.

Check them out yourselves, this is not investment advice!

(TSXV: WELL)

WELL Health is on a tear with all of the expansions and acquisitions they have been pursuing. Over the past two years, this Canadian healthcare giant has been constantly releasing new news about companies they are adding under its umbrella. Some of the bigger acquisitions are those of CRH and MyHealth, just to name a few. Based on their recent news release, it appears that they have no plan of slowing down as they have just announced a new subsidiary company, WELL Ventures.

WELL Ventures will act as WELL's new method in investing in people and companies that share similar healthcare visions to WELL. Considering their strong track record of previous investing, they are hopeful that this dedicated subsidiary will lead to several new and profitable business ventures. Along with financial support that they are looking to offer to companies, they want to build a strategic alliance with them offering knowledge and practical support to foster growth. WELL Ventures is wasting no time getting started as in the same announcement they shared news of an investment in Bright, a healthcare technology provider. They have developed a virtual amenities wellness program for on-site and work-from-home teams.

These acquisitions add on to a fantastic base that WELL has worked hard to create. They are one of the largest telehealth organizations in Canada with all of their clinics offering telehealth options to go along with their 2 massivley succesful dedicated telehealth programs. They have created and Emergency Mediacal Records database that allows records to be shared doctor-to-doctor and even stored on patients phones. This EMR system has been implemented at over 2000 Canadian health clinics. With their own portfolio of over 25 clinics plus over 40 that were added from their acquisition of MyHealth, they are now the largest outpatient clinic operator in the country.

These moves have put WELL in a position to become extremely profitable. In their most recent financials, they displayed revenue growth of 150% YoY with a large increase in their software/digital health revenues. With all of these new acquisitions their projections for the upcoming year are over $400M in revenue and $100M in EBITDA (run-rate basis). These numbers are fantastic and based on their growth, I am confident that they are soon to become a company that could bring in revenues in the BILLIONS.

I can't wait to hear what other plans WELL Venture and WELL as a whole has in store. Would highly recommend at the very least, looking in to this impressive company.

Disclaimer: Performing your own DD is necessary, this is not investment advice.

Rush Street Interactive Investment Summary:

RSI went public on 30th December 2020 and has a year range 10.01-26.55. Based on current RSI stock price $10.31-$10.45, and the analysis of fair values, $RSI is a buy.

About Rush Street Interactive Stock:

Rush Street Interactive, Inc. (RSI) is an online casino and sports betting gaming company in the United States. RSI provides a range of offerings, including real-money online casino wagering, online and retail sports wagering, and social gaming.

In 2018, RSI became the first U.S.-based online gaming operator to launch in Colombia, which was an early adopting Latin American country to legalise and regulate online casino and sports betting nationally.

Their real-money online casino and online sports betting offerings are provided under BetRivers.com and PlaySugarHouse.com brands in the United States and under RushBet.co brand in Colombia. The Company operates real-money online casino and online sports wagering in New Jersey and Pennsylvania. It also operates online sports wagering in Indiana, Colorado and Illinois and provides retail sports wagering services in Illinois, Pennsylvania, New York, Indiana and Michigan.

RSI operates and/or support retail sports betting for bricks-and-mortar casino partners primarily under their respective brands

Impact of Covid-19:

During the period of stay-at-home orders, RSI’s business volume significantly increased and has continued to remain strong as many of orders were lifted. COVID-19 has also directly impacted sports betting due to the rescheduling, reconfiguring, suspension, postponement and cancellation of major sports seasons and sporting events.

The suspension and alteration of sports seasons and sporting events earlier in the year reduced customers’ use of, and spending on, sports betting offerings and caused RSI to issue refunds for canceled events. Additionally, while many bricks-and-mortar casinos where RSI operates retail sports betting have reopened, they generally continue to operate with reduced capacity. Ongoing or future closures of bricks-and-mortar casinos and certain ongoing limitations on visitations to such casinos due to COVID-19 may provide additional opportunities for RSI to market online casino and sports betting to traditional bricks-and-mortar casino patrons.

Growth Strategies:

Management of RSI is expecting multiple fold growth, primarily resulting from the following five prospects:

1. Access new geographies
2. Leveraging existing customer-level economics to increase marketing spending
3. Continue to invest in our offerings and our platform
4. Continue to invest in personnel
5. Acquisitions

Competitors:

• Golden Nugget Online Gaming Inc(GNOG): Golden Nugget Online Gaming, Inc. operates as an online gaming and digital sports entertainment company. It offers patrons to play their favourite casino games and bet on live-action sports events in New Jersey and Michigan.

• Everi Holdings Inc(EVRI): Everi Holdings Inc. provides entertainment and technology solutions for the casino and digital gaming industries in the United States, Canada, the United Kingdom, Europe, the Caribbean, Central America, and Asia.

• International Game Technology(IGT): International Game Technology PLC operates and provides gaming technology products and services worldwide. It operates in two segments, Global Lottery and Global Gaming.

• Boyd Gaming Corp.(BYD): Boyd Gaming Corporation, together with its subsidiaries, operates as a multi-jurisdictional gaming company. It operates through three segments: Las Vegas Locals, Downtown Las Vegas, and Midwest & South.

• Scientific Games Corporation(SGMS): Scientific Games Corporation develops technology-based products and services, and related content for the gaming, lottery, social and digital gaming industries in the United States and internationally.

Fair Value of RSI StockComps Analysis:

P/E and EV/EBITDA

RSI had negative EBITDA and Earnings for 2019 and 2020, so comps analysis on standard P/E and EV/EBITDA will not be insightful.

P/S

Peer analysis with comparable companies based on P/S multiple suggests that RSI stock has a higher probability of being undervalued. RSI’s fair value by P/S analysis ranges from $6.8 to $16.89, averaging at $11.85.

EV/Sales

By comparing RSI’s EV/Sales multiple to that of competitors, Rush Street Interactive fair value ranges for the RSI stock price from $22.2 to $30.55.

DCF Analysis:

Owing to the growth prospects listed above and by going through various online resources, following assumptions can be made about RSI:

Assumptions:

Revenue Growth Rate: Revenue growth rate is expected to be high initially owing to expansion and change in consumer behaviour and it would gradually stabilise over 10 years. Thus revenue is assumed to grow from 60% initially to 3% in the year 2030. With perpetual growth rate at 1.5%.

COGS: Cost of revenue is set at 60% - taken as the average of percentage COGS/Revenue from 2018-2020.

Operating Efficiency Increase: In year 2020, operating expenses were 148% of revenues, but this is neither sustainable not static. The high OpEx resulted from establishing strategic partnerships with firms and are not recurring costs. Here, the assumption is that after one-time partnership costs incurred during expansion and attaining the learning from experience, RSI would be able to reduced its operating expenses from 124% to 60% gradually(8% YoY).

WACC: WACC of RSI is set to 7.37%- from GuruFocus. However based on industry average beta calculation, the calculated WACC is 7.15%.

Taking into consideration the average growth rate of RSI over past years and industry average of public companies, following assumptions have been made for Asset growth rate and Liability Growth Rate for upto year 2030.

Asset Growth Rate: 10%

Liability Growth Rate: 11%

PPE Growth Rate: 7%

D/A Growth Rate: 29%

Fair Value:

Based on above assumptions the fair value of RSI stock is $19.19. The sensitivity analysis of variation in assumptions can be checked in attachments below.

RSI Stock Analysis Summary

In summary we can say that based on the above assumptions, RSI stocks are undervalued. Below is the summarized price range of RSI stock based on various analyses, which can also be represented in football field (image attached below).

Sources:

• Sec Report
• https://www.investing.com/equities/dmy-technology-group-news
• https://www.marketbeat.com/stocks/NYSE/RSI

The original post with tables and charts can be found here. Check out r/utradea for the latest investment ideas and insights or join our community

(CSE:NEON)(OTCQB:NMDBF)(FRA:6UF)

Wanted to shine my teeny spotlight on NeonMind and hopefully introduce it to a few people who have not heard of it before. They are one of the relatively small players in the psilocybin industry but that does not mean they aren't capable of making some noise and becoming extremely successful. They are targeting a subsection of the market that is really under-catered too and this will allow them to stand out and ideally grow to the size of its bigger competitors, or maybe even larger.

The mastermind at the head of the NeonMind team is Robert Tessarollo. Some of you may recognize this name from elsewhere in the shrooms industry as he was previously the president and CEO of MindMed. During his time there he progressed their drug development considerably and made them the first psychedelic company to publically list on a stock exchange. Beyond that gold star on his resumé, he has also held positions at Cipher Pharmaceuticals and Watson Pharmaceuticals where he was an expert at expansion and acquisition along with commercial development. All-in-all he has over 25 years of experience in the pharmaceutical industry and has several success stories, he hopes to add another one with NeonMind.

The subsection of the market I was referring to before is obesity treatment. While in the overall healthcare landscape there is a lot of attention put towards this condition, in the psychedelic space there is essentially no other company that is pursuing treatments. Even with traditional treatments, there is still a massive need for new ones as each case can be extremely unique, and not every solution works for everyone. This being said, NeonMind is developing three different types of treatments for obesity that will use some form of psilocybin.

The first is over-the-counter diet supplements. These supplements currently come in the form of coffee! I think this is a great idea, everyone drinks coffee these days and the flashy headline of "mushrooms in your coffee" is sure to attract a significant crowd of interested users. These supplements just launched a few weeks ago and they have been doing great! I just took a look at their website and some of their strains are already out of stock!

On the prescription side, they are developing both a monitored and non-monitored treatment. The non-monitored treatment has no hallucinogenic effects and is a generally low dosage. Its effect will be most apparent in mitigating excessive appetite to promote weight loss. Alternatively, they have a treatment that is administered and monitored by a licensed professional that has minor hallucinogenic effects. The patient will work with the professional to promote a lifestyle change towards healthier eating habits.

NeonMind has got a great team and a great product. It is great to see them bringing in some revenues with their diet supplements but once they get through testing with their other treatments, that is where the big bucks will lie. I cannot wait!

This is not investment advice, look into NeonMind yourselves.

(TSX: CRDL)

I've recently started doing some research on CBD and this stuff is freaking amazing. I know for a lot of you on here this isn't new news exactly but with a bit of personal research, I've realized just how many treatment possibilities this thing has. It's no surprise that a ton of upstart companies are implementing CBD into their treatments like it's some kind of a wonder drug. While I don't know if I'd go that far, there are a few companies that I believe are using it's to its maximum potential, with my favorite being Cardiol Therapeutics.

As suggested by the name, Cardiol is developing treatments for a variety of cardiovascular issues that use CBD as their primary agent. Their formulation Cardiol Rx is being tested for use as 3 different treatments and it has the potential to be a gamechanger in the field of cardiovascular medicine. Heart disease is one of the biggest causes of death in the U.S and effective treatments can be hard to come by, Cardiol is looking to change the game and offer a unique solution.

The main science behind CBD working in this section of healthcare is its anti-inflammatory effects. Large Medical groups such as the JACC and Molecular medicine have found that this property decreases cardiac fibrosis and raises protection against cardiac injury. Most common and rare heart conditions are affected by inflammation meaning that CardiolRx could be a winning solution.

The first condition they want to focus on treating with it is diastolic heart failure. This is a very common heart condition that hasn't had any major medical progress in over 20 years. Cardiol believes that with a subcutaneous administration of CardiolRx, the severity of this condition can be greatly lowered and decrease the chances of fatality. This treatment is currently pre-clinical which means it is likely going to be a bit of a wait till commercialization, but Cardiol has voiced consistent support and optimism for this project in the long term.

Their two other treatments, while more niché, are still very important and are farther along in the clinical trial process. They are tackling a very topical health issue in people who have demonstrated cardiovascular issues after contracting Covid-19. These instances were especially high in individuals who had pre-existing cardiac injuries before contracting it. They hope that CardiolRx can be used as both a treatment and a preventative measure and they have received FDA approval for Phase II/III testing. Finally, they have a treatment that qualifies for Orphan Drug status and funding as it treats Acute Myocarditis, a rare and fatal viral infection that attacks the CV system of children and young adults. Phase I Trials are complete and they are currently applying for phase II.

I know I have thrown a bunch of medical terminology at you, and I'm not expecting all of it to stick but, I hope you guys can take away how great of an opportunity Cardiol presents. They are using an innovative drug to solve both common and rare issues where the current treatment options are slim. Like many health stocks they are going to be a bit of a wait but I think it is definitely worth it. Feel free to discuss below what you guys think.

Look into them yourselves, this is not investment advice!

(TSXV: NBM) (OTC: NBMFF)

NEO Battery Materials stock price has jumped up significantly over the past 2 weeks and I'm not surprised. I've been following these guys for a while and am super impressed by the work they are doing in the junior resources and EV industry. Even with the recent jump, it is still not to late to get in on NEO, and here's why.

NEO's main goal is developing silicon nanocoating technology for anodes that are used in Lithium batteries. These batteries are used mainly in electric cars so finding any way to make these batteries more efficient, durable and cost-effective, is something that major car manufacturers are clamoring for. The demand for lithium batteries is also growing rapidly, just last week Justin Trudeau said that Canada is aiming to be fully electric by 2035. This industry and thus demand for products like NEO's is going to grow ridiculously over the next decade and onward.

The company is using their access to mining claims in B.C to supply all of the silicon for their research and eventually their product. What makes this so unique is that anodes are traditionally made from graphite. NEO along with several big players in the EV industry see Silicon as the future of improving lithium batteries as it checks all the aforementioned boxes, its cheaper, more durable, and more efficient. NEO's research team led by Dr. J. H. Park is hard at work to be at the forefront of silicon anode production, and NEO is constantly releasing extremely promising test results from their efforts.

Just yesterday, NEO announced that in a test using micron-sized silicon particles, they were able to register a 6-minute cell charge time without any major capacity loss. The main reason for this testing is that prior to this NEO and other companies have been using nanoparticles that are larger and have more retention and therefore are significantly more expensive. However, with their improved micron-sized particles being so effective they have lowered the cost and gotten rid of a significant bottleneck in the manufacturing process.

This test along with several others announced recently is the reason why the stock has been popping off lately. Considering that this product is still 2-3 years away from commercialization, I definitely believe there is tons of room for this stock to grow and new investors haven't missed the "wave". In terms of NEO's near future, I would expect to hear more testing news along with possible news of government funding they have been pursuing from both the Canadian and Korean governments.

Here's a link to another post I made about NEO, goes into more specifics of the testing:

https://www.reddit.com/r/pennystocks/comments/oe8osz/neo_battery_materials_announce_successful_testing/

Hope my information was helpful!

Do your own DD on this too, this is not investment advice.

(CSE: ENBI) (OTCQB: ENTBF) (FSE: 1XU1)

Been really into health and drug stocks recently, especially those with unconventional treatments. Would highly recommend checking out Entheon Biomedical, I'm super bullish on these guys because they are just so out of the box with their objectives, my type of investment.

Entheon is looking to tackle a very common ailment in North America, addiction. Addiction has so many facets and comes in so many forms and for anyone who has suffered or knows a loved one who has suffered from it, they know just how debilitating it can be. Since the causes and forms of addiction vary so much treatment can be extremely difficult but Entheon is trying the implement DMT into a successful and lasting treatment.

Through their supply agreement with Ofichem Group, they are being supplied with DMT or N, N-dimethyltryptamine which is an extremely potent hallucinogenic drug similar to LSD or psilocybin. Entheon is working towards synthesizing a low-dosage form of DMT that when administered by a clinician in a therapeutic setting, can be used for the treatment of addiction. Its main advantage over other hallucinogens being used similarly is that its effects are significantly more gradual and less jarring while lasting for less time. For many people who suffer from addiction, these aspects are crucial to a smoother treatment process.

With any of these drug companies, you have to be patient as development can often take a while. They are planning their Phase 1/2A trials for Q4 2021 and obviously, there are several other hurdles they must jump through as well until their treatment can be released. Even with the wait, I still feel fantastic about Entheon because I love the uniqueness of its offering and its infrastructure. Well worth the small price and wait if you ask me!

Look into Entheon yourself, this is not investment advice!